Steroid-resistant focal segmental glomerulosclerosis treated with cascade plasmafiltration and rituximab

Copyright by Società Italiana di Nefrologia SIN, Rome, Italy..

A 39-year man with primary steroid resistant focal segmental glomerulosclerosis (FSGS) was treated with mycophenolate mofetil and ACE-inhibitors. After six months a different therapeutics approach was mandatory due to the worsening of renal function and the relapse of proteinuria at the nephrotic range. The combination of cascade plasmafiltration and single dose of rituximab (375 mg/m²) achieved clinical remission and improved renal function in six months follow up. Cascade plasmafiltration in association with rituximab can be considered as a salvage method for primary steroid-resistant FSGS. Clinical trials should be carried out for protocol approval.

Medienart:

E-Artikel

Erscheinungsjahr:

2018

Erschienen:

2018

Enthalten in:

Zur Gesamtaufnahme - volume:35

Enthalten in:

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia - 35(2018), 3 vom: 22. Mai

Sprache:

Italienisch

Beteiligte Personen:

Tatangelo, Paola [VerfasserIn]
Londrino, Francesco [VerfasserIn]
Di Vasta, Giorgio [VerfasserIn]
Guido, Giuliana [VerfasserIn]
Centi, Alessia [VerfasserIn]
Dominijanni, Sara [VerfasserIn]
Bernabei, Eleonora [VerfasserIn]
Caramiello, Maria Stella [VerfasserIn]
Di Franco, Damiano [VerfasserIn]
Palumbo, Roberto [VerfasserIn]

Themen:

4F4X42SYQ6
A0JWA85V8F
Adrenal Cortex Hormones
Angiotensin-Converting Enzyme Inhibitors
Atorvastatin
Cascade plasmafiltration
Case Reports
Diuretics
Focal segmental glomerular sclerosis
HU9DX48N0T
Immunosuppressive Agents
Mycophenolic Acid
Platelet Aggregation Inhibitors
Rituximab
Steroid-resistant focal segmental glomerular sclerosis

Anmerkungen:

Date Completed 21.06.2019

Date Revised 21.06.2019

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM284322407